Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ViThera Pharmaceuticals Inc.
DescriptionEngineered lactic acid and probiotic bacteria using EnLact technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today